𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Silencing of CDK5 as potential therapy for Alzheimer’s disease

✍ Scribed by López-Tobón, Alejandro; Castro-Álvarez, John Fredy; Piedrahita, Diego; Boudreau, Ryan L.; Gallego-Gómez, Juan Carlos; Cardona-Gómez, Gloria Patricia

Book ID
111859125
Publisher
Walter de Gruyter GmbH & Co. KG
Year
2011
Tongue
English
Weight
278 KB
Volume
22
Category
Article
ISSN
0334-1763

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cdk5, a therapeutic target for Alzheimer
Cdk5, a therapeutic target for Alzheimer's disease?
✍ Li-Huei Tsai; Ming-Sum Lee; Jonathan Cruz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Alzheimer's disease (AD) represents the leading cause for senile dementia affecting more than 4 million people worldwide. AD patients display a triad of pathological features including brain atrophy caused by neuronal loss, h-amyloid plaque and neurofibrillary tangles. We previously show that Cyclin